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Abstract
E-selectin is expressed by the activated endothelium and its plasma
levels are increased in patients with systemic sclerosis. Eighteen
patients fulfilling the American Rheumatism Association criteria
for systemic sclerosis, 15 females and 3 males, 42-70 years old, 9
with diffuse and 9 with limited forms, were sequentially recruited
for this study. Serum E-selectin levels were determined by commer-
cially available ELISA and their association with nailfold capillaro-
scopic abnormalities was investigated. Nailfold capillaries were
analyzed by 16X magnification wide-field capillaroscopy. Two pa-
rameters on capillaroscopy were used to correlate to serum E-
selectin: deletion and ectasia. Data were analyzed statistically by
the Student t-test and Spearman correlation. Two-tailed P values
below 0.05 were considered significant. E-selectin range was 38 to
200 ng/ml (80 ± 39.94). There was a correlation between serum E-
selectin levels and the deletion capillaroscopic score (r = 0.50, P <
0.035). This correlation was even stronger within the first 48 months
of diagnosis (r = 0.63, P < 0.048). On the other hand, no association
was observed between selectin and ectasia. Patients with diffuse
disease presented higher serum E-selectin levels than patients
with limited disease, although the difference was not statistically
significant (96.44 ± 48.04 vs 63.56 ± 21.77 ng/dl; P = 0.08). The
present study is the first showing a correlation between soluble
serum E-selectin levels and alterations in capillaroscopy. The stron-
ger correlation of deletion score in capillaroscopy in early disease
suggests that serum E-selectin levels might be a useful biochemi-
cal marker of disease activity in systemic sclerosis.
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Introduction
Systemic sclerosis is a disease of connec-
tive tissue characterized by thickening and
fibrosis of the skin and by involvement of
internal organs. In contrast to other rheumatic
autoimmune diseases, such as systemic lupus
erythematosus and rheumatoid arthritis, there
is no reliable disease activity marker for sys-
temic sclerosis. Early histologic changes in-
clude microvascular abnormalities and deposi-
tion of increased amounts of extracellular ma-
trix. Endothelial cell activation appears to be
one of the earliest features. Therefore, the
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endothelium is believed to play a central role in
the vascular pathophysiology of the disease
(1).
Early events in a standard inflammatory
process induce the expression of cellular
adhesion molecules which coordinate the
migration of leukocytes to the extravascular
sites involved (2). Soluble forms of adhesion
molecules, including intercellular adhesion
molecule-1 (ICAM-1), leukocyte function
associated molecule-3 (LFA-3), vascular
adhesion molecule-1 (VCAM-1), and E-se-
lectin have been detected in the plasma of
patients with systemic sclerosis as well as in
other autoimmune disorders, representing
potentially useful clinical markers (3,4).
In vitro cultures of scleroderma-derived
fibroblasts express significantly higher
amounts of surface ICAM-1 than normal
fibroblast cultures (5). Increased expression
of the VCAM-1 integrin ligand has also been
observed on the endothelium and stratum
granulosum on the skin of patients with early
systemic sclerosis (6).
E-selectin contains a lectin-like N-terminal
domain capable of recognizing the tetrasac-
charide sialyl-Lewisx moiety in monocytes and
neutrophils (7). E-selectin mediates a neutro-
phil adhesion pathway distinct from that medi-
ated by ICAMs and leukocyte integrins and
participates in early steps of neutrophil binding
to the endothelium, before transendothelial
migration (8). E-selectin is particularly inter-
esting because it is found only on the activated
endothelium in contrast to other adhesion
molecules which have a wide tissue distribu-
tion (9). A retrospective study indicated that its
circulating form is found at low levels in
healthy individuals and at elevated levels in the
sera of patients with systemic lupus erythema-
tosus, polyarteritis nodosa, and systemic scle-
rosis (10). Furthermore E-selectin serum lev-
els were higher among those patients with
recent onset active disease (10). Increased
tissue expression of E-selectin has been used to
demonstrate endothelial cell activation on the
skin of patients with systemic sclerosis (11).
Nailfold capillaroscopy is a routine proce-
dure in the investigation of patients with
Raynaud’s phenomenon and systemic sclero-
sis. Nailfold capillaries can be assessed by
microscopy, video capillaroscopy (12) and
ophthalmoscopy (13). Probably morphologi-
cal alterations can reflect disease activity. In a
study, 22 patients who had Raynaud’s phe-
nomenon, abnormal findings on capillaros-
copy and high soluble serum E-selectin devel-
oped characteristics that satisfied classifica-
tion criteria for systemic sclerosis within a 1-
to 7-year follow-up (14).
E-selectin seems to be a unique marker
for endothelial activation, being transiently
expressed on cultured endothelial cells 2-8 h
after in vitro stimulation and substantially
lost from the surface within 24 h (15). Since
microvascular disease is an important fea-
ture of systemic sclerosis, it is possible that
circulating E-selectin levels may reflect the
degree of in vivo endothelial cell activation
and the extent of capillaroscopic abnormali-
ties in systemic sclerosis.
In the present study we determined soluble
E-selectin levels in sera from patients with
systemic sclerosis and attempted to correlate
E-selectin levels with nailfold capillaroscopy.
Patients and Methods
Eighteen patients fulfilling the American
Rheumatism Association criteria for sys-
temic sclerosis (16), 15 females and 3 males,
42-70 years old, 9 with diffuse and 9 with
limited forms, were sequentially recruited
for this study from the Systemic Sclerosis
Spectrum Outpatient Clinic at the Medical
School Hospital of the São Paulo Federal
University. The medical charts of all patients
were reviewed to obtain age, sex, disease
subtype, and disease duration.
Nailfold capillaries were analyzed by 16X
magnification wide-field capillaroscopy con-
comitantly with blood sampling for E-selec-
tin determination. For each patient the nailfolds
of 4 fingers (excluding the thumb) on each
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hand were determined. Capillary abnormali-
ties were rated according to the protocol
proposed by Andrade et al. (17) with empha-
sis on quantitative and semiquantitative as-
sessment of capillary enlargement and devas-
cularization. The total number of enlarged
loops was divided by the number of exam-
ined fingers. Focal devascularization was
rated according to the deletion score pro-
posed by Lee et al. (18) as follows: grade 0
= no deletion areas, grade I = 1 or 2 discrete
deletion areas, grade II = more than two
discrete deletion areas, and grade III = exten-
sive and confluent deletion areas. Deletion
score was determined by the mean of the
deletion grades obtained in the fingers.
Two parameters on capillaroscopy were
used to correlate to serum E-selectin: deletion
score (as described above) and ectasia (total
number of enlarged loops per finger mean).
Serum samples were obtained and stored at
-70°C until analysis. Circulating E-selectin lev-
els were determined by a commercially avail-
able ELISA system (R & D, Oxford, UK),
according to the manufacturer’s protocol.
Data were analyzed statistically by the
Student t-test for comparison of E-selectin
levels in the diffuse and limited forms of the
disease. Spearman’s coefficient was used to
assess possible correlations between the nailfold
capillaroscopy parameters and serum E-selec-
tin concentration. Two-tailed P values below
0.05 were considered significant. All analyses
were carried out using the SPSS 8.0 software.
The study protocol was approved by the
University Ethics Committee and all patients
signed an informed consent document.
Results
E-selectin range was 38 to 200 ng/ml
(mean = 80 ± 39.94) and disease duration
was 64.94 ± 61.57 months. We observed
correlation between serum E-selectin levels
and the deletion score capillaroscopic pa-
rameter (r = 0.50, P = 0.035; Figure 1A).
This correlation was even stronger within
the first 48 months (median of disease dura-
tion) of diagnosis (r = 0.63, P = 0.048; Figure
1B). On the other hand, no association was
observed between selectin and ectasia. Pa-
tients with diffuse disease tended to present
higher serum E-selectin levels than patients
with limited disease, although the difference
was not statistically significant. The same
was observed when comparing patients with
Table 1. E-selectin and capillaroscopic parameters (ectasia and deletion score) between disease subset and disease duration.
Limited (N = 9) Diffuse (N = 9) P value ≤48 months (N = 10) >48 months (N = 8) P value All (N = 18)
Ectasia score 4.21 ± 2.99 4.64 ± 4.09 0.80 5.43 ± 3.61 3.15 ± 3.07 0.18 4.43 ± 3.48
Deletion score 0.93 ± 0.83 1.70 ± 1.08 0.11 1.38 ± 0.92 1.24 ± 1.19 0.78 1.31 ± 1.02
E-selectin
(ng/dl) 63.56 ± 21.77 96.44 ± 48.04 0.08 112.33 ± 44.95 60 ± 22.73 0.06 80 ± 39.94
N = number of patients. Data are reported as means ± SD (Student t-test).
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Figure 1. Correlation between
E-selectin and the deletion cap-
illaroscopic score in all patients
(A) and in those within the first
48 months of diagnosis (B)
(Spearman correlation).
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early (<48 months) and late disease (>48
months) (Table 1).
Discussion
In this study we have determined the
levels of E-selectin in serum samples from
patients with systemic sclerosis to investi-
gate a possible correlation with disease sub-
set and with capillaroscopic abnormalities.
Capillaroscopy has been reported to be use-
ful not only for early diagnosis, but also for
activity evaluation (18). Patients with diffuse
disease tended to present higher serum E-
selectin levels than those with limited dis-
ease, a fact that was more evident in patients
within the first 48 months of disease. This
result agrees with reports suggesting that
this adhesion molecule could reflect disease
severity in systemic sclerosis (4). This ob-
servation also agrees with the view that
diffuse disease may be associated with ex-
tensive endothelial activation as compared to
a restricted panorama in limited disease. If
this is correct, the study of a larger number
of patients would be expected to statistically
demonstrate our observed trend in serum E-
selectin levels between diffuse and limited
systemic sclerosis.
The most specific and prevalent capil-
laroscopic abnormalities of the disease are
ectasia and deletion. The deletion score was
correlated to E-selectin levels, but ectasia
was not, suggesting that E-selectin is associ-
ated with more severe disease.
An interesting observation was that the
correlation between deletion capillaroscopic
score and serum E-selectin levels increased
from 50 to 63% when considering all patients
and only patients within the first 4 years of
diagnosis, respectively. This observation
probably reflects the fact that elevated serum
levels of soluble adhesion molecules are pre-
dominantly observed in the early inflamma-
tory stages of systemic sclerosis (19,20).
Since the capillaroscopic abnormalities of
systemic sclerosis are structural, and there-
fore irreversible, in an advanced disease
stage, patients with long-standing disease
deletion might not present current endothelial
inflammatory disease and may be considered
to be merely a sequel of the disease. Thus, it
seems reasonable that the capillaroscopic
abnormalities observed in the first years of
disease should be more closely correlated
with current disease activity. In view of the
variability of the data, it is very likely that a
study with more patients would show statis-
tical significance in the levels of selectin
between the diffuse and limited forms of the
disease. However, the present data are rel-
evant because this is the first study showing
a correlation between soluble serum E-selec-
tin levels and alterations in capillaroscopy.
The stronger correlation with deletion
score in capillaroscopy in early disease sug-
gests that serum E-selectin levels might be a
useful biochemical marker of disease activity
in systemic sclerosis.
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